RxDoctor Payments Data

Jason Farrar

Pediatric Hematology-Oncology · Little Rock, ARNPI 1235283581

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Organogenesis Inc. at 38.1% of the total.

$171in general payments, 2019–2025

Across 8 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$65
  • Mimedx Group, Inc.$50
  • Medtronic$22
  • Novartis$17
  • Pfizer$17
$834,522in research payments, 2019–2025

Across 8 payments — averaging $104,315 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$829K
  • National Marrow Donor Program$6K

What the payments were for

  • Food & beverage$171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.3$65
Mimedx Group, Inc.2$50
Medtronic1$22
Novartis1$17
Pfizer1$17

How this compares

Too few pediatric hematology-oncology providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →